Rani Therapeutics Holdings (RANI) risk factors

Item 1A of every Rani Therapeutics Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open RANI in Gloom →

Rani Therapeutics Holdings' chart, financials and news, free in your browser.Open RANI in Gloom →

FY2025 10-K risk factors
109 risks8 new18 dropped11 reworded
Rani Therapeutics highlights new partnership risks with Chugai, NASDAQ listing compliance concerns, and international trade tariff uncertainties.
Filed Mar 26, 2026
FY2024 10-K risk factors
119 risks
Rani Therapeutics faces substantial going concern risks requiring immediate additional capital to sustain operations and avoid liquidation. The company relies heavily on the unproven RaniPill platform and biologic-device combination products. Strict regulatory hurdles and ongoing clinical trials dictate commercial feasibility.
Filed Mar 31, 2025